Close Menu

drug resistance

CHICAGO (GenomeWeb News) – An international team led by investigators from a company called the Cancer Therapeutic Innovation Group is using integrated genomics approaches to assess acquired resistance mechanisms in lung tumors treated with targeted therapy, attendees at the annual American Socie

This article has been updated from a previous version to clarify information regarding the development and commercialization of Zeesan Biotech's assays.

Nanomal, a European Union-funded public-private consortium developing a handheld device for rapid, point-of-care molecular diagnosis of malaria and drug resistance, said this week that the instrument is a year ahead of schedule and will be ready for field testing later this year.

WASHINGTON (GenomeWeb Daily News) — While cancer therapies targeted to the genetic makeup of patients' tumors have allowed for more precise treatment of disease, tumors bombarded with such drugs may develop resistance, even to such directed drugs.

Using mutation and gene expression patterns from non-Hodgkin's lymphoma cell lines, scientists from Genentech and elsewhere have come up with a gene expression signature for predicting response to a CD40 stimulating therapy called dacetuzumab that's being developed to treat B cell cancers.

Pages

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.